Press enter to see results or esc to cancel.

Oncocidia

The company is developing a targeted radiopharmaceutical cancer treatment called Oncocidia. This innovative treatment involves extending the already successful use of Iodine-131 in treating thyroid cancer to treat solid cancers (primary and metastatic) elsewhere in the body. Iodine-131 is used to label the necrosis avid agent hypericin. Hypericin targets necrosis in a tumor and carries …

Continue Reading

Tilt Biotherapeutics

TILT Biotherapeutics is a clinical-stage biotechnology company developing cancer therapeutics based on its proprietary oncolytic adenoviruses armed with molecules, including cytokines that can stimulate or suppress T cells. The company’s patented TILT technology, which can be delivered locally and systemically, modifies the tumor microenvironment and eliminates its ability to suppress immune responses to cancer, thereby …

Continue Reading

Pear Bio

Pear Bio is a computational biology company that uses organ-on-a-chip and computer vision technology to recreate, visualize and compute the human tumor microenvironment and its effects on cancer progression. The company is building an atlas of cancer progression to help research hospitals/pharma test experimental drugs and to help clinicians evaluate potential treatment options for each …

Continue Reading

Kaiku Health

Kaiku Health has developed a digital health intervention platform classified as a Medical Device in cancer care. Its algorithms screen symptoms, notify care teams and provide personalized support for patients. Kaiku Health has modules for over 25 cancer types across different cancer care pathways, enabling cancer clinics to provide optimized care through timely symptom management …

Continue Reading

Perci Health

Perci Health has developed a platform that supports people living with cancer and also goes beyond cancer through personalized programmes. Said programmes include support across the whole cancer continuum, from preparing for treatment to support during treatment, recovery and rehabilitation and return to work. To that end, Perci offers tailored answers and access to high-quality …

Continue Reading

Tailor Bio

With its AI-driven drug discovery platform, Tailor Bio is bringing precision medicine to the deadliest cancers. It provides clinical decision support to physicians, allowing them to select the best therapy for their patients’ treatments. To do this, Tailor Bio’s technology decodes chromosomal instability — a genomic phenomenon present in 80% of all cancers — and …

Continue Reading

MVision AI

MVision AI provides is a cloud-based software service provider for radiotherapy treatment planning. Its AI-powered automatic segmentation tool helps to standardize contouring and automate segmentation to streamline the radiotherapy treatment planning workflow. MVision’s deep learning model produces consistent contouring in minutes while maintaining the highest standards of quality for every patient, every time. As of …

Continue Reading

Kuano

Kuano combines quantum physics, AI and medicinal chemistry in an approach to transforming the discovery of therapeutics focused on enzyme inhibition. Enzymes represent the largest class of drug targets, with over $40 billion of pharmaceutical sales attributable to small molecule inhibitors of enzymes. The market is seeing considerable demand for enzyme inhibitors, which can provide …

Continue Reading

AMLo Biosciences

A spin-out from Newcastle University, AMLo Biosciences is developing predictive tests for cancers with unmet needs. Its first product is an immunohistochemical test for non-ulcerated, cutaneous melanomas, which can accurately identify those tumors at low risk of recurrence/spread, reducing patient anxiety associated with cancer.

Continue Reading

Artios Pharma

Artios is a leading independent DNA Damage Response (DDR) company focused on developing first-in-class treatments for cancers that are difficult to treat. Artios began clinical trials in February 2021 of its small-molecule ATR inhibitor, ART0380, in patients with advanced or metastatic solid tumors. The company is building a pipeline of next-generation DDR programs, including through …

Continue Reading

MyPL

MyPL has developed a personalized augmented medicine platform built on a global approach to patient data, which helps healthcare professionals to determine the personalized therapeutic strategies accurately to be implemented for a given patient, particularly in the case of cancer patients. This unique data visualization solution allows a large amount of data as well as …

Continue Reading

Kheiron Medical Technologies

Kheiron Medical is on a mission to help breast cancer patients live longer, better lives through earlier detection. Its solution, called Mia (Mammography Intelligent Assessment), combines new deep learning methods, data science, and radiology insights to help doctors find malignancies in mammograms. Whilst many AI technologies are not designed to be inclusive, Kheiron’s technology has …

Continue Reading

Mindpeak

MindPeak builds automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Its tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as the quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. The company …

Continue Reading

Elypta

Elypta is a molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome, which are system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer non-invasively. Elypta is advancing a broad clinical program across different cancers, with …

Continue Reading

Terapet

Terapet has developed an add-on device to improve existing proton therapy, which is an advanced form of radiotherapy for cancer treatment that can target tumors with extreme precision. It is a non-invasive medical device placed close to the patient during the treatment to enable doctors to monitor the delivered proton dose inside the patients during …

Continue Reading

Sarcura

Sarcura is developing an instrument platform for the GMP manufacturing of autologous cell therapies. Its platform combines microfluidic processing with silicon chip technology to enable real-time process control and manipulation on a cellular level supporting a fully automated manufacturing system. The company’s target is to scale global manufacturing capacity for patient-specific cell therapy cancer treatments …

Continue Reading

CancerAppy

CancerAppy has developed a platform based on Big Data and AI, specialized in the field of cancer research, developed by and for scientists and drug developers that fills the gap between basic data tools and pharma intelligence tools. Said platform is meant to efficiently and effectively de-risk the process of cancer drug discovery and development …

Continue Reading

Vinehealth

Founded in 2018, Vinehealth has built an app applying behavioral science and AI to deliver highly personalized support for cancer patients at scale. The platform also acts as a channel through which patients can be remotely monitored by their clinicians as they provide feedback on symptoms and report any treatment side effects. On the other …

Continue Reading